|
CN112076165A
|
|
Orally disintegrating tablet capable of freshening breath and preparation method thereof
|
|
CN112028784A
|
|
Preparation method of free L-lysine solid
|
|
CN111333581A
|
|
Synthetic method of ozagrel sodium
|
|
CN111419871A
|
|
Compound polyethylene glycol electrolyte granules and preparation method thereof
|
|
CN109406684A
|
|
A kind of detection method measuring impurity B in the Amino Acid Compound Injection containing tryptophan, C, D content
|
|
CN109172532A
|
|
A kind of itraconazole dispersible tablets and its preparation method and application
|
|
CN108853042A
|
|
A kind of Mirtazapine freeze-drying oral disintegrating tablet and its preparation method and application
|
|
CN110878017A
|
|
Refining and purifying method of L-malic acid for injection
|
|
CN110361457A
|
|
The HPLC detection method of 5 hydroxymethyl furfural content in medical product
|
|
CN110105245A
|
|
A kind of preparation method of Vernakalant intermediate 3,4- Dimethoxyphenethyl 2,2,2- tribromo-acetyl imines
|
|
CN110066235A
|
|
A kind of Oxiracetam crystal and its preparation method and application
|
|
CN109988083A
|
|
The preparation method of high-optical-purity escitalopram oxalate intermediate S configuration glycol
|
|
CN109988148A
|
|
1-(3- cyanopyridine -2) -2- phenyl -4- methyl piperazine oxalates preparation method
|
|
CN109988071A
|
|
The preparation method of hydrochloric acid Vernakalant intermediate 1R, 2R-2- (3,4- dimethoxyphenethoxy) cyclohexylamine salt
|
|
CN106727523A
|
|
A kind of preparation method of 18 Amino Acid Compound Injections without antioxidant and pH adjusting agent and products thereof
|
|
CN105367571A
|
|
Method for synthesizing mirtazapine
|
